Dysmenorrhea
📧 Sign up to get email alerts when something new happens for Dysmenorrhea.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-14FDA Approved: CELECOXIB — Original Application (Modavar Pharmaceuticals LLC)
The FDA approved Modavar Pharmaceuticals LLC's original application for a generic version of celecoxib (Celecoxib).
-
CLINICAL_TRIALS trial_result · 2019-10-28Clinical Trial Update: A Study to Assess Menstrual Cramp Pain Associated With Primary Dysmenorrhea [Phase 4]
A Phase 4 clinical trial evaluating menstrual cramp pain in primary dysmenorrhea has been completed, with results posted in 2019.
-
FDA approval · 2019-10-26FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., resulting in an approved modification to the product’s lab…
-
FDA approval · 2019-10-09FDA Approved: CELECOXIB — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Celecoxib submitted by Actavis Pharma, Inc.
-
CLINICAL_TRIALS trial_result · 2019-09-19Clinical Trial Update: Sublingual Tablets With Cannabinoid Combinations for the Treatment of Dysmenorrhea [Phase 2]
Phase 2 clinical trial exploring sublingual tablets with cannabinoid combinations for dysmenorrhea and related symptoms.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-07FDA Approved: CELECOXIB — Original Application (AiPing Pharmaceutical, Inc.)
The FDA approved AiPing Pharmaceutical, Inc.'s original ANDA for celecoxib, establishing a generic version of the COX-2 inhibitor. The appro…
-
FDA approval · 2019-07-25FDA Approved: CELECOXIB — Supplemental Application (Aurobindo Pharma Limited)
FDA approves Aurobindo Pharma Limited's supplemental application for Celecoxib (generic Celecoxib), confirming the generic's approval. Celec…
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for ibuprofen from Chartwell RX, LLC under ANDA 202413, authorizing the specified changes to thi…
-
FDA approval · 2019-07-22FDA Approved: IBUPROFEN — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for ibuprofen by Amneal Pharmaceuticals of New York LLC.
-
CLINICAL_TRIALS trial_result · 2019-06-25Clinical Trial Update: Traditional Chinese Medicine, Western Medicine and Low-level Light Therapy（LLLT） for Primary Dysmenorrhea（PD） [Phase 4]
Phase 4 trial update exploring traditional Chinese medicine, Western medicine, and low-level light therapy for primary dysmenorrhea.
-
FDA approval · 2019-05-06FDA Approved: DICLOFENAC SODIUM — Original Application (Harris Teeter)
FDA approved Harris Teeter's diclofenac sodium as a generic under an original ANDA.
-
CLINICAL_TRIALS trial_result · 2019-05-03Clinical Trial Update: Assessment of a Vaginal Ring With Meloxicam in the Treatment of Dysmenorrhea [Phase 2, Phase 3]
Phase 2/3 clinical trial update evaluating a vaginal ring containing meloxicam for the treatment of dysmenorrhea has completed.
-
CLINICAL_TRIALS trial_result · 2019-04-16Clinical Trial Update: Efficacy and Safety, Long-Term Study of NPC-16 to Treat Dysmenorrhea [Phase 3]
Phase 3 trial update on NPC-16 for dysmenorrhea reports efficacy and safety findings from long-term study.
-
CLINICAL_TRIALS trial_result · 2019-03-27Clinical Trial Update: Observational Prospective Study to Evaluate AEs, Risk Factors and Drug Utilization of BUSCAPINA COMPOSITUM N in Adults From Metropolitan Lima
An observational prospective study assessing adverse events, risk factors, and utilization of Buscapina Compositum N in adults; completed wi…
-
CLINICAL_TRIALS trial_result · 2019-03-26Clinical Trial Update: Effect of KYG0395 on Primary Dysmenorrhea [Phase 2]
A Phase 2 clinical trial evaluating KYG0395 for primary dysmenorrhea has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Neuromodulatary Efficacy of Transcranial Direct Current Stimulation in Severe Refractory Primary Dysmenorrhea [NA]
This is an update on a completed trial evaluating transcranial direct current stimulation for severe refractory primary dysmenorrhea.
-
CLINICAL_TRIALS trial_result · 2019-02-15Clinical Trial Update: Efficacy of Transcranial Direct Current Stimulation for Severe Primary Dysmenorrhea [NA]
A completed clinical trial evaluated the efficacy of transcranial direct current stimulation for severe primary dysmenorrhea.
-
CLINICAL_TRIALS trial_result · 2019-02-05Clinical Trial Update: Danshen-Jiang-Fu Granule Prepared by Danshen From Different Producing Areas for Primary Dysmenorrhea [EARLY_Phase 1]
Early-phase (Phase 1) trial of Danshen-Jiang-Fu Granule for primary dysmenorrhea has completed. The granule is prepared from Danshen sourced…
-
CLINICAL_TRIALS trial_result · 2018-12-05Clinical Trial Update: A Double Blind, Double Dummy, Randomized, Comparative Study Of The Efficacy And Safety Of Valdecoxib 40 Mg Twice Daily, As Needed In The First Menstrual Cycle Day And Then Once A Day, And Piroxicam 40 Mg Once A Day In The Treatment Of Patients With Primary Dysmenorrhea [Phase 4]
Clinical trial comparing valdecoxib and piroxicam for primary dysmenorrhea; Phase 4 completed assessing efficacy and safety.
-
FDA approval · 2018-11-29FDA Approved: NAPROXEN SODIUM — Supplemental Application (Bionpharma Inc.)
FDA approved a supplemental application for Naproxen Sodium from Bionpharma Inc., confirming regulatory clearance for an updated product-rel…
-
CLINICAL_TRIALS trial_result · 2018-08-31Clinical Trial Update: Efficacy and Safety Study of Meloxicam Versus Mefenamic Acid in Patients With Dysmenorrhea [Phase 2]
Phase 2 trial comparing meloxicam to mefenamic acid in dysmenorrhea completed.
-
FDA approval · 2018-07-25FDA Approved: ALEVE GELCAPS — Supplemental Application (Bayer HealthCare LLC.)
The FDA approved Bayer's supplemental application to add ALEVE GELCAPS (naproxen sodium) as an additional formulation of naproxen products.
-
CLINICAL_TRIALS research · 2018-06-19Clinical Trial Update: The Effect of Zumba Dance on Primary Dysmenorrhea [NA]
A Cairo University-sponsored clinical trial update examining whether Zumba dance can alleviate symptoms of primary dysmenorrhea; the study s…
-
CLINICAL_TRIALS research · 2018-06-13Clinical Trial Update: Pulsed Electromagnetic Field Treatment for Painful Periods [NA]
This entry reports a clinical trial evaluating pulsed electromagnetic field treatment for dysmenorrhea (painful periods). The current status…
-
CLINICAL_TRIALS trial_result · 2018-05-01Clinical Trial Update: The Effectiveness and Safety of LIVIA® Transcutaneous Electrical Nerve Stimulation (TENS) in Women Suffering From Primary Dysmenorrhea. [Phase 2]
This update reports results from a Phase 2 trial evaluating the effectiveness and safety of LIVIA Transcutaneous Electrical Nerve Stimulatio…